ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2315

Foxp3+ Treg Cells Decreased in Overexpression of T-Bet in PD-1 Deficient Mice

Masahiro Tahara1, Yuya Kondo1, Hiroto Tsuboi2, Satoru Takahashi3, Isao Matsumoto1 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 2Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 3Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba city, Ibaraki, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: death, regulatory cells and transcription factor, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Programmed cell Death-1 (PD-1) plays an important role in peripheral T cell tolerance, therefore PD-1 deficient (PD-1 KO) mice develop strain-specific autoimmune phenotypes. C57BL/6 (B6) background PD-1 KO mice develop glomerulonephritis after 24-48 weeks of age, which is similar to human endocapillary proliferative glomerulonephiritis observed in lupus nephritis. The differentiation of Th cells in PD-1 KO mice was not fully elucidated. The purpose of this study is to clarify the effect of T cell specific T-bet overexpression on autoimmune disease in PD-1 KO mice.
 
Methods:  
1) T-bet overexpressing PD-1 KO mice were generated by crossing T-bet transgenic (T-bet Tg) mice under the promoter of CD2 gene with PD-1 KO mice (PD-1 KO x T-bet Tg mice ; P/T mice). 2) In wild-type (WT) mice, PD-1 KO mice, T-bet Tg mice and P/T mice, the pathological evaluation of the kidneys was performed with H·E, PAS and PAM staining at 6-8 weeks of age. Deposition of IgG and C3 in kidneys was analyzed with immunofluorescence staining. 3) The histological analyses were evaluated on the heart, spleen, mesenteric LN, lung, liver, pancreas, salivary gland and lacrimal gland with H·E staining and immunofluorescence staining in WT mice, PD-1 KO mice, T-bet Tg mice and P/T mice. 4) Proportion of lymphocytes subset and cytokine production by CD4+ T cells in spleen was analyzed by FACS. 5) FACS analysis was performed to evaluate transcription factor expression on CD4+ T cells in spleen.
 
Results:
1) Most of P/T mice died within 10 weeks. 2) Glomerulonephritis was not observed in WT mice, PD-1 KO mice, T-bet Tg mice and P/T mice. Deposition of IgG and C3 was observed in glomeruli in PD-1 KO mice, but not in WT mice, T-bet Tg mice and P/T mice. 3) Splenomegaly and infiltration of mononuclear cells in liver were observed only in P/T mice. Immunofluorescence staining revealed that infiltrating cells were CD3+ T cells. 4) FACS analysis showed that the total cell number was increased in P/T mice (15.3 ± 3.11 x107cells), compared with WT mice (6.41 ± 0.81 x107cells, P<0.05 by Mann-Whitney U-test), PD-1 KO mice (8.46 ± 1.77 x107cells, P=0.086) and T-bet Tg mice (7.12 ± 2.32 x107cells, P=0.086), and IFN-γ production on CD4+ T cells observed in P/T mice (20.5 ± 3.42%) was higher than that in WT mice (3.56 ± 0.63%, P<0.05) and PD-1 KO mice(6.85 ±1.17%, P<0.05). 5) Percentage of Foxp3+ cells in CD4+ Treg cells was significantly decreased in P/T mice (2.47 ± 1.31%), compared with WT mice (13.4 ± 1.39%), PD-1 KO mice (16.9 ± 2.15%) and T-bet Tg mice (19.1 ± 2.55%) (P<0.05).
 
Conclusion:
In P/T mice, the reduced percentage of Foxp3+CD4+ Treg cells induced systemic inflammation, resulting in short-life span.


Disclosure:

M. Tahara,
None;

Y. Kondo,
None;

H. Tsuboi,
None;

S. Takahashi,
None;

I. Matsumoto,
None;

T. Sumida,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/foxp3-treg-cells-decreased-in-overexpression-of-t-bet-in-pd-1-deficient-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology